PubMed Health⌕ Search

PubMed · 8129359

Subspecialisation in medicine.

Abstract

The explosive expansion of scientific knowledge over recent decades has made it difficult for individuals to stay abreast of a single specialty. This, together with specific developments within certain fields, has established a need for expertise at a subspecialist level. The advantages of this development are that clinicians can concentrate their efforts, linking with experts of similar interests, by journals, meetings and networking databases. Similarly, provided a patient reaches the appropriate subspecialist, they can be sure of up-to-date skilled management by a recognised expert in a centre of excellence. The disadvantages of this trend are the obligatory early entry into specialist training and the inevitable decline of the generalist clinician, increasing the risks of inappropriate diagnosis and inappropriate referral. The introduction of a subspecialty will usually increase overall costs and therefore has to be justified by improved quality of care, while not being detrimental to other aspects of health care delivery. The implications at a national level are on undergraduate as well as postgraduate training, and also on the provision of appropriate funding for the sub-specialty and its infrastructure. Although there are many potential pathways for achieving standards of excellence in medical care, subspecialisation provides one of the most appropriate ways of developing, promoting and expanding a field. Such expansion, however, must be accompanied by thorough audit, to justify its independent existence.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J S Lumley. 1993. Subspecialisation in medicine.. https://pubmed.ncbi.nlm.nih.gov/8129359/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Global Genomic Surveillance.

Global genomic surveillance has emerged as a foundational pillar of public health in the twenty-first century, enabling real-time tracking of pathogen evolution and informing outbreak response. This chapter examines the strategic architecture of global genomic surveillance, focusing on its application to arboviruses such as chikungunya virus (CHIKV). It explores the integration of genomic data with epidemiological, clinical, and environmental information within a One Health framework, while addressing critical challenges in governance, equity, and interoperability. The discussion covers the entire genomic surveillance workflow, from sample collection and sequencing to bioinformatic analysis and phylogenetic inference, and highlights the transformative role of artificial intelligence (AI) in predictive surveillance. By analyzing global initiatives, operational barriers, and emerging technologies, this chapter underscores the necessity of sustainable, equitable, and interoperable genomic systems to proactively address current and future infectious disease threats.

Humans↗

Systematic Dissection of Key Driver Perturbation Signatures in Single Cells via ECCITE-seq.

CRISPR screens, such as expanded CRISPR-compatible cellular indexing of transcriptomes and epitopes by sequencing (ECCITE-seq), enable the simultaneous measurement of transcriptomes, gRNA identity, and cell-surface protein expression at single-cell resolution to systematically interrogate gene function. This platform provides a powerful and scalable experimental approach for validating disease-associated regulators identified by large-scale association studies and other computational methods, including network-based analyses of multi-omics data. Here, as an example application, we describe an ECCITE-seq framework to characterize the transcriptomic consequences of perturbing multiple neuronal key driver genes associated with Alzheimer's disease (AD) in human-induced pluripotent stem cell (hiPSC)-derived neurons. More broadly, by integrating customized pooled gRNA libraries with different CRISPR effectors across multiple cell types, this approach allows for the assessment of the regulatory impact of candidate genes implicated in development and disease processes.

Humans↗

Identification of Genome-Wide Chromatin Structural Aberration in Cancer by Hi-C Analysis.

Aberrant three-dimensional genome organization is a hallmark of cancer, often driving oncogene activation through mechanisms such as enhancer hijacking. High-throughput chromosome conformation capture (Hi-C) maps these interactions on a genome-wide scale. Unlike earlier dilution-based methods, in situ Hi-C performs proximity ligation within intact nuclei, minimizing random ligation noise and enabling fine-scale structure detection. This chapter describes an optimized in situ Hi-C protocol tailored for cancer cell lines using MboI digestion and biotin-mediated pull-down to generate high-complexity libraries. We further outline a computational workflow that extends beyond standard topological mapping of compartments and topologically associating domains to identify cancer-specific aberrations. Specifically, we focus on detecting chromosomal rearrangements (structural variants) and characterizing the distinct circular topology of extrachromosomal DNA. This integrated experimental and analytical framework provides the necessary tools to dissect the spatial dysregulation underlying tumor evolution.

Humans↗